Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality.
Giouliana Kadra-ScalzoR StewartH ShettyJ H MacCabeChin-Kuo ChangD TaylorR D HayesPublished in: Acta psychiatrica Scandinavica (2018)
The findings suggest that the effect of long-term APP on mortality is not clear-cut, with limited evidence to indicate an association, even after controlling for the effect of dose.